Get started

ATAI

ATAI Life Sciences | ATAI | Long at $1.30ATAI Life Sciences NASDAQ:ATAI , a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, is fast approaching my selected historical simple moving average (SMA). Often, but not always, the closer the price gets to this line, the higher chance there is for a fast upward move. In anticipation of this move, NASDAQ:ATAI is in a personal buy zone at $1.30. A word of caution: this is a pure technical analysis play and this company is not expected to be profitable for many, many years... Target #1 = $1.75 Target #2 = $2.50 Target #3 = $2.95
NASDAQ:ATAILong
by NicksAnalysis
ATAI - 2 potential paths to $5After successfully surpassing the previous swing high with considerable volume, attaining a fresh 52-week peak of $2.85, and witnessing the 50-day moving averages intersecting the 150 and 200 SMAs, ATAI appears poised for a reversal from its downtrend. **Potential Scenarios:** **Scenario 1: Triangular Consolidation (Orange)** ATAI may undergo consolidation within a triangular pattern marked by points A to E. This consolidation phase could indicate a period of indecision in the market as buyers and sellers balance their positions. Typically, triangular patterns suggest that volatility is decreasing, leading to an impending breakout. If this pattern unfolds as expected, a breakout is anticipated around mid-August, potentially triggering a significant move in the stock price. **Scenario 2: Corrective Pattern (Yellow)** Alternatively, the stock might experience a corrective phase represented by an A-B-C pattern. This corrective pattern could indicate a temporary pullback or retracement within the broader uptrend. Such corrections often serve to alleviate overbought conditions and provide an opportunity for new buyers to enter the market. In this scenario, ATAI is expected to establish a higher low by mid-August, reinforcing the bullish momentum and setting the stage for further upside potential. **Price Targets:** Anticipated Fibonacci targets include 1.414 ($4.45) or 1.616 ($5.54) to be achieved by year-end. These Fibonacci extensions are commonly used by traders to identify potential levels of resistance or support based on previous price movements. Additionally, a more ambitious target exceeding $15 within the next few years is also envisaged. This long-term target reflects the potential for ATAI to capitalize on emerging trends and developments within its industry, driving sustained growth and shareholder value over time.
NASDAQ:ATAILong
by joshuashepherd877
2
ATAI short-term playHello bulls, This one is a short-term play and can't much be said about it. After CMPS crushed, price dropped to 12$ and then due to Macro economical panic, crabbed around 11$. This is good that it's crabbing around 11$ because the next steps are the slow stairs to the 15$. Volume on last hour of December 3 indicates strong interest in 10.5-11$, meaning any further panic would just keep crabbing the stock. In my opinion, if the stock doesn't close at 13$ by end of December, sell. Because it will not be a short-term swing anymore. My average is 12$, stop loss at 10$. Pros: -Exposure to ATAI assets: 400M cash, 21% stake in CMPS and it's own proper research and development pipeline -Lower the price, higher interest to invest by Dealers or keep their assets protected from too much price fluctuation downward. -Correlation to the Psychedelic sector, specifically CMPS trend. Cons: -No Revenue to backup FA, only assets. -Can't sustain price floor above 11.5$ theses last 3 weeks of bloodbath. Let's hope confidence will be coming back. -Long term not recommended since the company burns cash per quarter. Unless you are investing in speculation. Overall, ATAI resisting to the panic better than BABA. This is not a financial advise and risk should be always taken in count before trading. Take care!
NASDAQ:ATAILong
by DumpItAgain